THE NEUROMEDICAL CENTER — History
CCN 193090 | 3-year financial timeline | COVID resilience: 57/100
🛡️ Public data only — no PHI permitted on this instance.
$10M
Latest Revenue (FY2022)
+5.4%
Revenue CAGR (3yr)
13.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $9M | $10M | $10M | +6.0% | +5.4% |
| Operating Expenses | $8M | $9M | $9M | +0.8% | +5.5% |
| Operating Margin | 13.1% | 8.5% | 13.0% | +53.0% | -0.4% |
| Net Income | $1M | $1M | $1M | +62.2% | +5.0% |
| Licensed Beds | 27 | 27 | 27 | +0.0% | +0.0% |
| Total Patient Days | 7,647 | 8,088 | 8,543 | +5.6% | +5.7% |
| Medicare Day % | 35% | 32% | 37% | +17.2% | +3.1% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 57/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +11.1% ($9M → $10M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▶ Stable
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+5.4%
This Hospital
+7.6%
State Avg
Latest Margin
13.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $11M | 12.9% |
| FY2024 (proj) | $11M | 12.9% |
| FY2025 (proj) | $12M | 12.8% |